Can Freeze-Dried Strawberries Improve Prediabetes Markers?

Thirty-two grams of freeze-dried strawberry powder per day improved insulin-resistance and glucose markers in adults with prediabetes in a small randomized trial. That is more useful than generic advice to eat more fruit: it gives a food, dose, population, and timeline to examine.

The result deserves interest, not canonization. The trial included only 25 people, used a single-blind crossover design, and had a washout period too short to cleanly interpret its HbA1c result. Strawberries may be a reasonable addition to an overall prediabetes plan. They are not a substitute for the parts of that plan with deeper evidence, especially exercise, weight management, and broader dietary change.

What the strawberry trial found

In a 2025 randomized controlled crossover trial by Arpita Basu and colleagues, 25 adults with prediabetes consumed 32 g daily of freeze-dried strawberry powder for 12 weeks, followed by a 4-week washout and a 12-week no-strawberry control period. The dose is roughly equivalent to two cups of fresh strawberries.

Compared with the control period, the strawberry period lowered HOMA-IR, a calculation based on fasting glucose and insulin that estimates insulin resistance, by 2.3 units (95% CI, -3.4 to -1.3; P<0.05). Fasting glucose fell by 8.9 mg/dL (95% CI, -13.2 to -4.7; P<0.05). Total cholesterol fell by 7.0 mg/dL (95% CI, -12.0 to -2.0; P<0.05).

The researchers also reported statistically significant reductions in fasting insulin, HbA1c, high-sensitivity C-reactive protein, interleukin-6, and body weight during the strawberry period. Fasting insulin fell by 6.9 μIU/mL and HbA1c by 0.2 percentage points, but the available publication information does not report confidence intervals for those two estimates. That omission matters: a point estimate tells you the study's best estimate, while a confidence interval shows how much room remains for chance and sampling error.

For someone whose fasting glucose is in the usual prediabetes range of 100 to 125 mg/dL, an 8.9 mg/dL difference would be meaningful if it holds up. But this trial measured biomarkers over 12 weeks, not diabetes diagnoses, cardiovascular events, or complications. It showed improvement in risk markers, not proof that strawberries prevent type 2 diabetes.

Why this is better than a nutrition headline

The study tested a real-food dose in the population most relevant to the question: adults who already had impaired glucose regulation. It also used a crossover design, so participants served as their own comparators across study periods. That can reduce some between-person noise.

Still, crossover studies depend on a clean reset between periods. The 4-week washout is a particular problem for HbA1c. HbA1c reflects average blood glucose exposure across roughly 90 to 120 days of red-blood-cell life. A month cannot fully erase the prior period's glycemic history, so treatment effects may carry into the next period. The available report does not provide treatment-period interaction statistics or washout values that would let readers judge the size of that carryover.

That concern is not academic nitpicking. In the Keto-Med randomized crossover trial, researchers compared ketogenic and Mediterranean diets in people with prediabetes or type 2 diabetes using 17-week diet periods and longer washouts. Larger dietary interventions can produce HbA1c changes comparable to or greater than the strawberry trial's 0.2-point reduction. The strawberry finding therefore looks modest beside comprehensive diet changes, even before considering its design limits.

The result may be about polyphenol-rich foods, not strawberries alone

Strawberries contain fiber, vitamins, and polyphenols, including anthocyanins and ellagic acid. A 2025 review of strawberry intake and health outcomes describes biological reasons these compounds could affect inflammatory and metabolic markers. Biological plausibility helps make a finding worth testing. It does not establish that one compound caused the trial's result.

There is human evidence for one candidate compound, but it is not a strawberry trial. In a 2021 double-blind, placebo-controlled trial, Mahnaz Ghadimi and colleagues gave isolated ellagic acid to people with established type 2 diabetes and reported improvements in glycemic status, insulin resistance, antioxidant capacity, and inflammatory markers. Ellagic acid occurs in strawberries, but an isolated compound at pharmaceutical doses in type 2 diabetes does not reproduce whole freeze-dried fruit in prediabetes. Absorption, dose, and metabolic context all differ.

Nor does the evidence support calling strawberries uniquely effective. A 2025 trial of microencapsulated polyphenols from persimmon and karonda found cardiometabolic and fitness improvements in overweight or obese adults with prediabetes who also completed resistance and aerobic training. Those polyphenols were dominated by non-strawberry anthocyanins, and the proposed inflammatory pathways overlapped with those discussed for strawberries. But exercise was part of the intervention, so the study cannot isolate whether polyphenols, training, or their combination produced the changes.

The sensible conclusion is narrower: the Basu trial offers preliminary evidence for this strawberry protocol. It does not establish that strawberries outperform blueberries, blackberries, other polyphenol-rich foods, or exercise.

Exercise remains the sturdier metabolic lever

Insulin resistance responds to several interventions. In a 2025 randomized trial of 70 sedentary people with prediabetes, three weekly sessions of low-volume high-intensity interval training—three 20-second cycling sprints per session—improved insulin sensitivity more than walking alone over 12 weeks. A separate network meta-analysis of exercise interventions in prediabetes concluded that multiple exercise approaches improve glycemic control and insulin resistance compared with no exercise.

That does not make a food intervention pointless. It puts it in proportion. Strawberries can fit within a diet that supports glucose control; they should not become the lone project while physical activity, sleep, medication decisions, and overall food intake sit untouched.

How to use the finding without overselling it

If you have prediabetes, 32 g per day of freeze-dried strawberry powder for 12 weeks is a specific, food-based experiment with a favorable practicality profile. Add it to unsweetened yogurt, oatmeal, or a smoothie rather than using it to turn a dessert into a laboratory instrument. The study tested powder, not strawberry-flavored products, sweetened dried berries, or a supplement with an impressive label and a mysterious amount of actual strawberry.

• Use the tested dose: 32 g daily of freeze-dried strawberry powder, approximately two cups of fresh strawberries.
• Keep the rest of your routine stable enough to interpret changes. Starting a new exercise program, losing weight rapidly, and changing breakfast every day at the same time will make any result hard to assign.
• Track fasting glucose and, if available through a clinician, fasting insulin and HOMA-IR before and after the trial period.
• Interpret HbA1c on its own timetable. It reflects several months of glucose exposure, and the strawberry crossover study's short washout makes its HbA1c estimate less secure.
• Discuss changes with a clinician if you use glucose-lowering medication or have diabetes rather than prediabetes.

The tested dose is a tested dose, not a proven minimum, maximum, or optimal dose.

The strawberry trial gives a promising signal: lower HOMA-IR and fasting glucose after 12 weeks in a small prediabetes-specific crossover study. Its size, blinding limitations, and HbA1c carryover problem keep it preliminary. Eat strawberries if you enjoy them and can use the tested form consistently. Build the larger strategy around interventions that already have broader support.